Faxitron awarded exclusive distribution rights for Breast Lesion Localization System The LOCalizer AMSTERDAM, Jan. 26, 2017 /PRNewswire/ — Faxitron® Bioptics, LLC and Health Beacons, Inc. today announced that Faxitron has been awarded exclusive worldwide distribution rights for Health Beacons’ RFID (Radio Frequency…Read More
Health Beacons named Innovative Healthcare Tech of the Year Finalist by MassTLCRead More
San Diego, CA — May 1, 2014 — Dr. Christine Dauphine, Director of the Breast Clinic at Harbor-UCLA Medical Center, will be presenting the results of the first set of human cases using Health Beacons’ radiofrequency identification (RFID) breast tumor localization system at the American Roentgen Ray Society (ARRS) 2014 Annual Meeting on May 4th in San Diego. The ARRS is a medical radiology society dedicated to advances in imaging technology.Read More
The goal of this investigation is to obtain clinical data to show the Health Beacons Radiofrequency Identification (RFID) Localization System is safe and performs as intended as a localization device for marking and retrieving a non-palpable surgical target from the breast.Read More
Health Beacons is a medical device company that designs and manufactures marking systems to help physicians navigate surgical procedures. The company’s RFID Localization System, or LOCalizer™, is a tool designed to provide guidance to surgeons during the removal of non-palpable breast lesions. Refer to the LOCalizer™ IFU for specific Indications for Use.
Health Beacons, Inc. products are protected by one or more U.S. patents or patent pending applications in the United States.
LOCalizer™ is Rx only.